Approval summary for bortezomib for injection in the treatment of multiple myeloma. [electronic resource]
Producer: 20050103Description: 3954-64 p. digitalISSN:- 1078-0432
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- therapeutic use
- Boronic Acids -- therapeutic use
- Bortezomib
- Clinical Trials as Topic
- Drug Approval
- Female
- Humans
- Male
- Middle Aged
- Models, Chemical
- Multiple Myeloma -- drug therapy
- Proteasome Endopeptidase Complex -- metabolism
- Pyrazines -- therapeutic use
- Time Factors
- United States
- United States Food and Drug Administration
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.